名稱 | PD1/41BB Dual Effector Reporter Cell |
型號(hào) | CBP74172 |
報(bào)價(jià) | ![]() |
特點(diǎn) | PD1/41BB Dual Effector Reporter Cell |
產(chǎn)品搜索
相關(guān)文章
- 人結(jié)腸癌細(xì)胞株的細(xì)胞形態(tài)是不太規(guī)則的三角形
- 【產(chǎn)品推介】TIGIT靶點(diǎn)細(xì)胞篩選模型
- 腫瘤細(xì)胞的凋亡與壞死有何區(qū)別?
- 腫瘤細(xì)胞培養(yǎng)實(shí)驗(yàn)的主要用途
- 【現(xiàn)貨上線】HRR-Related-28 Gene標(biāo)準(zhǔn)品
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
- 關(guān)于sigma試劑的使用時(shí)長相關(guān)說明
- CD200/CD200R篩選模型
- 免疫療法對(duì)一類常見白血病顯療效
- BCMA靶點(diǎn)藥物細(xì)胞篩選模型
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74172PD1/41BB Dual Effector Reporter Cell

- 詳細(xì)內(nèi)容
CBP74172 | |
I. Background | |
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. diabetes. Human CD137 (4-1BB; TNFRS9) is an inducible costimulatory molecule that activates T cells. CD137-CD137L mediated signaling has been shown to be important for proliferation, effector functions and survival of T cells. CD137 is also expressed in NK and NKT cells. Antibodies targeting CD137 activation in immune cells have demonstrated potent anti-tumor effects in cancer patients. | |
II. Introduction | |
Expressed gene: | PD1、41BB |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin+10ug/ml blasticidin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
III. Representative Data | |
Figure 1. Dose Response of Blocking Antibodies in PD-1/41BB Dual Effector Reporter Cells (C64) With PD-L1 aAPC Cells. | |